Zika virus in the eye of the cytokine storm.


Journal

European cytokine network
ISSN: 1952-4005
Titre abrégé: Eur Cytokine Netw
Pays: France
ID NLM: 9100879

Informations de publication

Date de publication:
01 Sep 2019
Historique:
entrez: 21 1 2020
pubmed: 21 1 2020
medline: 19 5 2020
Statut: ppublish

Résumé

Zika virus (ZIKV) is an emerging arbovirus that causes a mosquito-borne disease. Although infection with ZIKV generally leads to mild disease, its recent emergence in the Americas has been associated with an increase in the development of the Guillain-Barré syndrome in adults, as well as with neurological complications, in particular congenital microcephaly, in new-borns. Over the five past years, through the combined efforts of the scientific community, comprehensive remarkable progress aimed at deciphering the clinical, virological, physiopathological, and immunological features of ZIKV infection. This review highlights some of the most recent advances in our understanding of the role of cytokines and chemokines in ZIKV infection, and discusses potential links to pathogenesis.

Identifiants

pubmed: 31957701
pii: ecn.2019.0433
doi: 10.1684/ecn.2019.0433
doi:

Substances chimiques

Cytokines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

74-81

Auteurs

Christopher Maucourant (C)

Sorbonne Universités, UPMC Univ Paris 06, INSERM U1135, CNRS ERL8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.

Gabriel Andrade Nonato Queiroz (GAN)

Advanced Laboratory of Public Health/IGM-Oswaldo Cruz Foundation (FIOCRUZ), Rua Waldemar Falcão, no 121, Candeal, Salvador, Bahia CEP 40296-710, Brazil, Bahiana School of Medicine and Public Health, Salvador, Bahia, Brazil.

Assia Samri (A)

Sorbonne Universités, UPMC Univ Paris 06, INSERM U1135, CNRS ERL8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.

Maria Fernanda Rios Grassi (MFR)

Advanced Laboratory of Public Health/IGM-Oswaldo Cruz Foundation (FIOCRUZ), Rua Waldemar Falcão, no 121, Candeal, Salvador, Bahia CEP 40296-710, Brazil, Bahiana School of Medicine and Public Health, Salvador, Bahia, Brazil.

Hans Yssel (H)

Sorbonne Universités, UPMC Univ Paris 06, INSERM U1135, CNRS ERL8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.

Vincent Vieillard (V)

Sorbonne Universités, UPMC Univ Paris 06, INSERM U1135, CNRS ERL8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH